Cargando…

Expression of the Nonclassical MHC Class I, Saha-UD in the Transmissible Cancer Devil Facial Tumour Disease (DFTD)

Devil facial tumour disease (DFTD) is a transmissible cancer that has circulated in the Tasmanian devil population for >25 years. Like other contagious cancers in dogs and devils, the way DFTD escapes the immune response of its host is a central question to understanding this disease. DFTD has a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussey, Kathryn, Caldwell, Alison, Kreiss, Alexandre, Skjødt, Karsten, Gastaldello, Annalisa, Pye, Ruth, Hamede, Rodrigo, Woods, Gregory M., Siddle, Hannah V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953681/ https://www.ncbi.nlm.nih.gov/pubmed/35335675 http://dx.doi.org/10.3390/pathogens11030351

Ejemplares similares

Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils
por: Pye, Ruth, et al.
Publicado: (2016)

Tasmanian devil cathelicidins exhibit anticancer activity against Devil Facial Tumour Disease (DFTD) cells
por: Petrohilos, Cleopatra, et al.
Publicado: (2023)

Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils
por: Tovar, Cesar, et al.
Publicado: (2017)

Devil Facial Tumour Disease (DFTD): Using Genetics and Genomics to Investigate Infectious Disease in an Endangered Marsupial
por: Bender, Hannah S.
Publicado: (2010)

The role of MHC genes in contagious cancer: the story of Tasmanian devils
por: Caldwell, Alison, et al.
Publicado: (2017)

Inbreeding depression in one of the last DFTD-free wild populations of Tasmanian devils
por: Gooley, Rebecca M., et al.
Publicado: (2020)

Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells
por: Patchett, Amanda L., et al.
Publicado: (2018)

New Insights into the Role of MHC Diversity in Devil Facial Tumour Disease
por: Lane, Amanda, et al.
Publicado: (2012)

Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours
por: Ong, Chrissie E. B., et al.
Publicado: (2022)

The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer
por: Caldwell, Alison, et al.
Publicado: (2018)

Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases
por: Kwon, Young Mi, et al.
Publicado: (2018)

Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells
por: Ong, Chrissie E. B., et al.
Publicado: (2019)

The antiproliferative and apoptotic profile of gomesin against DFTD
por: Ikonomopoulou, Maria P., et al.
Publicado: (2018)

How the devil facial tumor disease escapes host immune responses
por: Siddle, Hannah V, et al.
Publicado: (2013)

Isotopic niche variation in Tasmanian devils Sarcophilus harrisii with progression of devil facial tumor disease
por: Bell, Olivia, et al.
Publicado: (2021)

Antigen-presenting genes and genomic copy number variations in the Tasmanian devil MHC
por: Cheng, Yuanyuan, et al.
Publicado: (2012)

Darwin, the devil, and the management of transmissible cancers
por: Hamede, Rodrigo, et al.
Publicado: (2020)

NK cell education via nonclassical MHC and non-MHC ligands
por: He, Yuke, et al.
Publicado: (2017)

Untangling the model muddle: Empirical tumour growth in Tasmanian devil facial tumour disease
por: Hamede, Rodrigo K., et al.
Publicado: (2017)

Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release
por: Pye, Ruth, et al.
Publicado: (2018)

Disruption of Metapopulation Structure Reduces Tasmanian Devil Facial Tumour Disease Spread at the Expense of Abundance and Genetic Diversity
por: Durrant, Rowan, et al.
Publicado: (2021)

Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors
por: Howson, Lauren J., et al.
Publicado: (2014)

Casting a wider net: Immunosurveillance by nonclassical MHC molecules
por: D’Souza, M. Patricia, et al.
Publicado: (2019)

Measurement of $R_{uds}$
por: Stacey, A M
Publicado: (1996)

Evolution and lineage dynamics of a transmissible cancer in Tasmanian devils
por: Kwon, Young Mi, et al.
Publicado: (2020)

Tracing the rise of malignant cell lines: Distribution, epidemiology and evolutionary interactions of two transmissible cancers in Tasmanian devils
por: James, Samantha, et al.
Publicado: (2019)

Variants in the host genome may inhibit tumour growth in devil facial tumours: evidence from genome-wide association
por: Wright, Belinda, et al.
Publicado: (2017)

The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
por: Kosack, Lindsay, et al.
Publicado: (2019)

UD. es el Jefe /
por: Josefowitz, Natasha
Publicado: (1994)

Vincristine Chemotherapy Trials and Pharmacokinetics in Tasmanian Devils with Tasmanian Devil Facial Tumor Disease
por: Phalen, David N., et al.
Publicado: (2013)

The Devil's Advocate
por: Woods, Caspian
Publicado: (2013)

Natural Killer Cell Mediated Cytotoxic Responses in the Tasmanian Devil
por: Brown, Gabriella K., et al.
Publicado: (2011)

Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease
por: Tovar, Cesar, et al.
Publicado: (2018)

Challenges of an Emerging Disease: The Evolving Approach to Diagnosing Devil Facial Tumour Disease
por: Espejo, Camila, et al.
Publicado: (2021)

Es Ud. un buen gerente? /
por: Dichter, Ernest, 1907-1991
Publicado: (1990)

Spatial variation in gene expression of Tasmanian devil facial tumors despite minimal host transcriptomic response to infection
por: Kozakiewicz, Christopher P., et al.
Publicado: (2021)

The evolution of two transmissible cancers in Tasmanian devils
por: Stammnitz, Maximilian R., et al.
Publicado: (2023)

Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii)
por: Ujvari, Beata, et al.
Publicado: (2016)

The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines
por: Patchett, Amanda L., et al.
Publicado: (2016)

Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma
por: Vetter, C S, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_oieokn6urb2mavkhsqvaa7mn5a